Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
See Tai Sandi
Chief Development Officer at Lexeo Therapeutics. Filing since 19 Feb 2025.
CIK 0002009350
Company
Date
Role
Action
Shares
Amount
Of holding
LXEO
Lexeo Therapeutics, Inc.
18 Nov 2025
Chief Development Officer
Sold at will
386
$3.58K
0.6%
LXEO
Lexeo Therapeutics, Inc.
17 Oct 2025
Chief Development Officer
Sold at will
3,888
$34.77K
5.6%
LXEO
Lexeo Therapeutics, Inc.
18 Aug 2025
Chief Development Officer
Sold at will
382
$1.78K
0.6%
LXEO
Lexeo Therapeutics, Inc.
16 May 2025
Chief Development Officer
Sold at will
367
$1.02K
0.6%
LXEO
Lexeo Therapeutics, Inc.
19 Feb 2025
Chief Development Officer
Sold at will
1,486
$6.56K
2.7%
5 decisions on file.
